Melanie Saville talks to Gary Humphreys about the specific challenges faced in developing and distributing SARS-CoV-2 vaccines and the need to fund end-to-end approaches to support those aims.
Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine